Access cutting-edge systemic sclerosis treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access systemic sclerosis specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related systemic sclerosis treatment provided free
This study investigates the efficacy and safety of belimumab compared to placebo, in addition to standard therapy, for the treatment of participants with systemic sclerosis associated interstitial lung disease (SSc-ILD). The study will evaluate the effect of belimumab treatment on lung function as well as on extra-pulmonary disease manifestations, including skin thickening and general symptoms, such as fatigue, that impact quality of life (QoL).
Sponsor: GlaxoSmithKline
Check if you qualify for this systemic sclerosis clinical trial in Phoenix, AZ
If you're searching for systemic sclerosis treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced systemic sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.